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Abstract
ROVABIO® SPIKY is a preparation of endo-1,4-beta-xylanase and endo-1,3(4)-beta-glucanase that is
authorised as a feed additive for chickens and turkeys for fattening, chickens reared for laying, turkeys
reared for breeding, minor poultry species for fattening and reared for laying. The EFSA Panel on
Additives and Products or Substances used in Animal Feed (FEEDAP Panel) issued two opinions on this
additive. Safety aspects regarding the use of this additive in feed have been previously established.
The Panel concluded that the additive is safe for the consumers and the environment and that the
additive is not irritant to the skin or eyes but should be considered a potential skin sensitiser and
potentially harmful if inhaled. The Panel considered that these conclusions are still valid for the current
application. The current application covered the use of the additive in all poultry species at the dose of
1,100 U xylanase and 760 U glucanase per kg feed. In previous assessments, the Panel concluded that
the additive is safe and efﬁcacious under the proposed conditions of use in chickens and turkeys for
fattening or raised for laying/breeding and to minor poultry species for fattening or raised for laying/
breeding. In order to support the safety for laying animals, the applicant provided a tolerance trial in
laying hens from which the Panel concluded that the additive is safe for laying hens at the
recommended dose. The safety established in laying hens is considered to apply also to breeding hens
and can be extrapolated to minor poultry species for laying. Regarding the efﬁcacy the additive
increased the metabolisable energy content of the diets in one trial and the performance of the laying
hens in two trials at the recommended dose. Therefore, the FEEDAP Panel concluded that the additive
has the potential to be efﬁcacious in laying hens. This conclusion applies also to breeding hens and
can be extrapolated to include all minor poultry species for laying.
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Summary
Following a request from the European Commission, the Panel on Additives and Products or
Substances used in Animal Feed (FEEDAP Panel) was asked to deliver a scientiﬁc opinion on the safety
and efﬁcacy of ROVABIO® SPIKY (endo-1,4-beta-xylanase and endo-1,3(4)-beta-glucanase) as a feed
additive for all poultry species. This additive is available in solid and liquid forms and is prepared by
combining two products of fermentation obtained from two strains of Penicillium funiculosum
(Talaromyces versatilis sp. novus) (IMI 378536 and DSM 26702), one of which is non-genetically
modiﬁed and the other is genetically modiﬁed.
The additive is authorised as a feed additive for chickens and turkeys for fattening, chickens reared
for laying, turkeys reared for breeding, minor poultry species for fattening and reared for laying. The
FEEDAP Panel issued an opinion in 2014 on the safety and efﬁcacy of ROVABIO® SPIKY (endo-
1,4-beta-xylanase and endo-1,3(4)-beta-glucanase) as a feed additive for chickens for fattening,
chickens reared for laying and other minor poultry species (for fattening and reared for laying). This
opinion considered the safety aspects of the additive regarding the consumer, the user, the
environment and the genetic modiﬁcation of one of the production strains. Another opinion was
adopted in 2015 regarding the use of the additive as a feed additive for turkeys.
Safety aspects regarding the use of this additive in feed including the safety for the consumers, for
the users and for the environment have been previously established. The Panel concluded that the
additive is safe for the consumers and the environment and that the additive is not irritant to the skin
or eyes but should be considered a potential skin sensitiser and potentially harmful if inhaled. The
FEEDAP Panel is not aware of any new information that would lead it to reconsider the conclusions
drawn previously. Moreover, the FEEDAP Panel considers that the new use would not modify any
conclusion.
The current application covered the use of the additive in all poultry species at the dose of 1,100 U
xylanase and 760 U glucanase per kg feed. In previous assessments, the FEEDAP Panel concluded that
the additive is safe and efﬁcacious under the proposed conditions of use in chickens and turkeys for
fattening or raised for laying/breeding and to minor poultry species for fattening or raised for laying/
breeding.
In order to support the safety for laying animals, the applicant provided a tolerance trial in laying
hens. On the basis of the results obtained in that tolerance trial, the Panel concluded that the additive
is safe at the recommended dose. In the view of the Panel, the safety established in laying hens
applies also to breeding hens. Moreover and considering the wide margin of safety demonstrated, the
Panel considers that the conclusion can be extrapolated to minor poultry species for laying.
The applicant submitted three efﬁcacy studies (one short-term trial and two long-term trials) in
laying hens in order to support the efﬁcacy for laying birds at the recommended dose of 1,100 U
xylanase and 760 U glucanase per kg feed. The addition of the additive at the recommended dose
increased the metabolisable energy content of the diets in one trial and the performance of the hens
in two trials. Therefore, the FEEDAP Panel concluded that the additive has the potential to be
efﬁcacious in laying hens at the recommended dose. The Panel considers that the efﬁcacy established
in laying hens applies also to breeding hens and that as the mode of action of xylanase and glucanase
can be reasonably assumed to be the same in all avian species, the conclusions on the efﬁcacy for
laying hens can be extrapolated to include all minor poultry species for laying.
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1. Introduction
1.1. Background and Terms of Reference
Regulation (EC) No 1831/20031 establishes the rules governing the Community authorisation of
additives for use in animal nutrition. In particular, Article 4(1) of that Regulation lays down that any
person seeking authorisation for a feed additive or for a new use of a feed additive shall submit an
application in accordance with Article 7.
The European Commission received a request from Adisseo France S.A.S.2 for authorisation of the
product ROVABIO® SPIKY (endo-1,4-beta-xylanase and endo-1,3(4)-beta-glucanase), when used as a
feed additive for all poultry species (category: zootechnical additive; functional group: digestibility
enhancers).
According to Article 7(1) of Regulation (EC) No 1831/2003, the Commission forwarded the
application to the European Food Safety Authority (EFSA) as an application under Article 4(1)
(authorisation of a feed additive or new use of a feed additive). EFSA received directly from the
applicant the technical dossier in support of this application. The particulars and documents in support
of the application were considered valid by EFSA as of 7 December 2015.
According to Article 8 of Regulation (EC) No 1831/2003, EFSA, after verifying the particulars and
documents submitted by the applicant, shall undertake an assessment in order to determine whether
the feed additive complies with the conditions laid down in Article 5. EFSA shall deliver an opinion on
the safety for the target animals, consumer, user and the environment and on the efﬁcacy of the
product ROVABIO® SPIKY (endo-1,4-beta-xylanase and endo-1,3(4)-beta-glucanase), when used
under the proposed conditions of use (see Section 3.1).
1.2. Additional information
The additive ROVABIO® SPIKY is a preparation of endo-1,4-beta-xylanase (xylanase: EC 3.2.1.8)
and endo-1,3(4)-beta-glucanase (glucanase: EC 3.2.1.6) and is available in solid and liquid forms
(ROVABIO® SPIKY AP and ROVABIO® SPIKY LC, respectively). This additive is prepared by combining
two products of fermentation obtained from two strains of Penicillium funiculosum (Talaromyces
versatilis sp. novus) (IMI 378536 and DSM 26702).
The Panel on Additives and Products or Substances used in Animal Feed (FEEDAP Panel) issued an
opinion on the safety and efﬁcacy of ROVABIO® SPIKY as a feed additive for chickens for fattening,
chickens reared for laying and other minor poultry species (for fattening and reared for laying) (EFSA
FEEDAP Panel, 2014). This opinion considered the safety aspects of the additive regarding the
consumer, the user, the environment and the genetic modiﬁcation of one of the production strains.
Another opinion was adopted in 2015 regarding the use of the additive as a feed additive for turkeys
(EFSA FEEDAP Panel, 2015).
The additive is authorised as a feed additive for chickens and turkeys for fattening, chickens reared
for laying, turkeys reared for breeding, minor poultry species for fattening and reared for laying.3,4
2. Data and methodologies
2.1. Data
The present assessment is based on data submitted by the applicant in the form of a technical
dossier5 in support of the authorisation request for the use of ROVABIO® SPIKY (endo-1,4-beta-
xylanase and endo-1,3(4)-beta-glucanase) as a feed additive. The technical dossier was prepared
1 Regulation (EC) No 1831/2003 of the European Parliament and of the Council of 22 September 2003 on additives for use in
animal nutrition. OJ L 268, 18.10.2003, p. 29.
2 Adisseo France S.A.S., Immeuble Antony Parc II 10, Place du General de Gaule, 92160 Antony, France.
3 Commission implementing Regulation (EC) 2015/661 of 28 April 2015 concerning the authorisation of the preparation of endo
1,4-beta-xylanase and endo-1,3(4)-beta-glucanase produced by Talaromyces versatilis sp. nov. IMI CC 378536 and Talaromyces
versatilis sp. nov. DSM 26702 as a feed additive for chickens for fattening, chickens reared for laying and minor poultry species
for fattening and reared for laying (holder of the authorisation Adisseo France S.A.S.). OJ L 110, 29.4.2015, p. 1.
4 Commission Implementing Regulation (EC) 2015/2304 of 10 December 2015 concerning the authorisation of a preparation of
endo-1,4-beta-xylanase and endo-1,3(4)-beta-glucanase produced by Talaromyces versatilis sp. nov. IMI CC 378536 and
Talaromyces versatilis sp. nov. DSM 26702 as a feed additive for turkeys for fattening and for breeding (holder of the
authorisation Adisseo France S.A.S.). OJ L 326, 11.12.2015, p. 39.
5 FEED dossier reference: FAD-2015-0032.
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following the provisions of Article 7 of Regulation (EC) No 1831/2003, Regulation (EC) No 429/20086
and the applicable EFSA guidance documents.
The European Union Reference Laboratory (EURL) considered that the conclusions and
recommendations reached in the previous assessment are valid and applicable for the current
application.7
2.2. Methodologies
The approach followed by the FEEDAP Panel to assess the safety and the efﬁcacy of ROVABIO®
SPIKY (endo-1,4-beta-xylanase and endo-1,3(4)-beta-glucanase) is in line with the principles laid down
in Regulation (EC) No 429/2008 and the relevant guidance documents: Guidance on zootechnical
additives (EFSA FEEDAP Panel, 2012a), Technical guidance: tolerance and efﬁcacy studies in target
animals (EFSA FEEDAP Panel, 2011), Technical Guidance: extrapolation of data from major species to
minor species regarding the assessment of additives for use in animal nutrition (EFSA, 2008), Guidance
for establishing the safety of additives for the consumer (EFSA FEEDAP Panel, 2012b), Guidance on
studies concerning the safety of use of the additive for users/workers (EFSA FEEDAP Panel, 2012c).
3. Assessment
The additive is authorised as a feed additive for chickens and turkeys for fattening, chickens reared
for laying, turkeys reared for breeding, minor poultry species for fattening and reared for laying. The
current application covers the use of the additive in all poultry species. The safety and efﬁcacy of this
additive in poultry species for fattening or reared for laying/breeding has been previously established.
In the current assessment, the Panel assesses the safety and efﬁcacy of the product as a feed additive
for laying/breeding birds.
3.1. Characterisation of the additive
The additive was described in full in a previous opinion (EFSA FEEDAP Panel, 2014) and no new
information has been provided.
The additive ROVABIO® SPIKY is a preparation of endo-1,4-beta-xylanase (xylanase: EC 3.2.1.8)
and endo-1,3(4)-beta-glucanase (glucanase: EC 3.2.1.6) and is available in solid and liquid forms
(ROVABIO® SPIKY AP and ROVABIO® SPIKY LC, respectively). This additive is prepared by combining
two products of fermentation obtained from two strains of P. funiculosum (Talaromyces versatilis sp.
novus) (IMI 378536 and DSM 26702).
The analysis of the enzyme activities in the additive is performed following two methods: a
viscosimetric-based method (viscosimetric units (U))8 or a method based on the colour formation of
released sugars with 3,5-dinitrosalicylic acid (DNS U).9 Per gram of solid product, the minimum
speciﬁed activity is of 22,000 U or 2,300 DNS U for xylanase activity and 15,200 U or 1,600 DNS U for
glucanase activity. Per millilitre of liquid product, the minimum speciﬁed activity is of 5,500 U or
570 DNS U for xylanase activity and 3,800 U or 400 DNS U for glucanase activity.
The additive is intended to be used in feed for poultry at a recommended dose of 1,100 xylanase
viscosimetric units and 760 glucanase viscosimetric units per kg feed.
3.2. Safety
Safety aspects regarding the use of this additive in feed including the safety for the consumers, for
the users and for the environment have been previously established (EFSA FEEDAP Panel, 2014). The
Panel concluded that there are no concerns for consumer safety and no risks for the environment are
expected. The Panel also concluded that both forms of the additive are not irritant to the skin or eyes
6 Commission Regulation (EC) No 429/2008 of 25 April 2008 on detailed rules for the implementation of Regulation (EC)
No 1831/2003 of the European Parliament and of the Council as regards the preparation and the presentation of applications
and the assessment and the authorisation of feed additives. OJ L 133, 22.5.2008, p. 1.
7 The full report is available on the EURL website: https://ec.europa.eu/jrc/sites/default/ﬁles/FinRep-FAD-2013-0030-Rovabio
Spiky.pdf
8 One xylanase (or beta-glucanase) viscosity unit (U) is deﬁned as the amount of xylanase (or beta-glucanase) that hydrolyses
wheat arabinoxylan (or barley beta-glucan), reducing the solution viscosity, in order to change the relative ﬂuidity by one
dimensionless unit per minute, at pH 5.5 and 30°C.
9 One xylanase (or beta-glucanase) DNS unit corresponds to the amount of xylanase (or beta-glucanase) which liberates from
the birchwood xylan (or barley beta-glucan) 1 µmol of xylose (or glucose) per minute at 50°C and pH 4.0 (or pH 5.0).
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but should be considered a potential skin sensitiser and potentially harmful if inhaled. The FEEDAP
Panel is not aware of any new information that would lead it to reconsider the conclusions drawn
previously. Moreover, the FEEDAP Panel considers that the new use would not modify the above
conclusions.
The current application covers the use of the additive in all poultry species. In previous
assessments, the FEEDAP Panel concluded based on tolerance trials in chickens and on turkeys for
fattening that the additive is safe under the proposed conditions of use in chickens and turkeys for
fattening or raised for laying/breeding and to minor poultry species for fattening or raised for laying/
breeding. The solid and liquid forms of the additive are considered to be equivalent in terms of safety
for the target species.
In order to support the safety for laying animals, the applicant provided a tolerance trial in laying hens.
3.2.1. Safety for laying hens
A total of ﬁve hundred and seventy-six 21-week-old Hy-Line-Brown laying hens were placed in
enriched cages in groups of eight hens.10 The cages were allocated to three dietary treatments
considering the location in the battery as a block. There were in total 24 replicates per treatment. A basal
diet based on wheat, maize and soya bean meal was either not supplemented (control) or supplemented
with ROVABIO® SPIKY AP to provide (xylanase/glucanase) 2,200/1,520 (29 recommended dose) or
220,000/152,000 (2009)U/kg feed (conﬁrmed by analysis). Diets were offered ad libitum as mash for
56 days. Health status and mortality of the animals were monitored throughout the study. Body weight
was measured at the beginning and at the end of the trial, with measurements done on a cage basis.
Feed intake was monitored throughout the study every 4 weeks. All eggs produced were collected and
weighed every second day. Feed to egg mass ratio was calculated per replicate and period. At the end of
the study, a total of 192 eggs per treatment were evaluated for weight of eggshell, yolk, albumen, Haugh
units and egg yolk colour. An ANOVA was performed on the data obtained, cage being the experimental
unit, and means were compared with the Duncan’s test. Differences were considered signiﬁcant at
p < 0.05.
No hens died during the experiment, health status was good and no major incidences occurred
during the study. No differences between treatments were found on the feed intake (115.6, 116.3,
114 g/hen per day for control, 29 and 2009, respectively), egg production (91.8%, 93.4% and
92.5%), average egg weight (57.8, 57.8 and 57.4 g/egg), daily egg mass output (53.1, 54.0 and
53.0 g/day), or feed to egg mass ratio (2.18, 2.16 and 2.15). Body weight gain of the hens was
signiﬁcantly improved by the 2009 diet compared to the control diet (3.1, 3.4, 3.9 g/day for control,
29 and 2009, respectively). No differences were found in the egg quality parameters measured.
Supplementation of the experimental diet with 200-fold the recommended dose did not have
adverse effects on the performance of the birds.
3.2.1.1. Conclusions on the safety for laying birds
On the basis of the results obtained in the tolerance trial in laying hens, the Panel concludes that
the additive is safe at the recommended dose. In the view of the Panel, the safety established in
laying hens applies also to breeding hens. Moreover and considering the margin of safety
demonstrated, the Panel considers that the conclusion can be extrapolated to minor poultry species for
laying.
3.3. Efﬁcacy
In previous assessments, the FEEDAP Panel evaluated the efﬁcacy in chickens and turkeys for
fattening and concluded that the additive is efﬁcacious at 1,100 U xylanase and 760 U glucanase per
kg feed. The conclusion was extended to chickens reared for laying and turkeys reared for breeding
and it was extrapolated to minor poultry species for fattening or reared for laying/breeding. The solid
and liquid forms of the additive are considered to be equivalent in terms of efﬁcacy for the target
species.
The applicant has submitted studies (one-short term trial and two long term trials) in laying hens,
in order to support the efﬁcacy for laying birds.
10 Technical dossier/Section III/Annex III.1.1 and Supplementary information May 2016/Annex 1.
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3.3.1. Efﬁcacy for laying hens
3.3.1.1. Short-term trial
Sixty 23-week-old Shaver 477 Brown laying hens individually caged were used.11 The hens received
a prestarter diet based on wheat, soya bean meal and barley for 2 weeks. Egg production was
monitored during the last 10 days. At the end of week 25 and after a 2-h fasting period in the dark,
40 hens were selected (according to laying rate and body weight), individually caged and allocated to
two dietary treatments, representing 20 replicates of one hen per treatment. A basal diet based on
wheat, barley and soya bean meal was either not supplemented (control) or supplemented with
ROVABIO® SPIKY LC to provide 1,100 U xylanase and 760 U glucanase per kg feed (conﬁrmed by
analysis). Diets were offered ad libitum as pellets for 14 days. After an adaptation period of 9 days,
excreta were collected for 5 days. Excreta and feed were analysed in order to study the AME content
of the feed. The AME values were corrected for nitrogen (AMEn). Hens were weighed at the start of
the experimental period, before the collection of excreta and at the end of the collection period. Egg
production was monitored daily. An ANOVA was performed on the data. Differences were considered
signiﬁcant at p < 0.05. The results are given in Table 1.
No hens died during the experiment. No differences between treatments were observed in the
body weight of the animals, the laying rate, the egg weight and mass, the feed intakes and feed
conversion ratios. The treatment had no effect on egg quality characteristics. The AME and AMEn were
improved by the treatment.
3.3.1.2. Long-term trials
In the ﬁrst long-term trial, a total of six hundred and seventy-two 21-week-old Lohmann Brown
laying hens were placed in enriched cages in groups of 21 hens and allocated to two dietary
treatments, representing 16 replicates per treatment.12 A basal diet based on triticale and soya bean
meal was either not supplemented (control) or supplemented with ROVABIO® SPIKY AP to provide
1,100 U xylanase and 760 U glucanase per kg feed (conﬁrmed by analysis). Diets were offered
ad libitum in mash form for 168 days. Health status and mortality of the animals were monitored
biweekly throughout the study. Body weight was measured at the beginning and at the end of the
trial. Feed intake was monitored biweekly throughout the study. All eggs produced were collected and
weighed. Feed to egg mass ratio was calculated. On the last week of the study, 21 eggs per cage
were analysed for egg shell and albumen weight and in four eggs per cage, egg yolk colour was
measured. An ANOVA was performed on the data with the cage as the experimental unit. Differences
were considered signiﬁcant at p < 0.05. The results are given in Table 2.
Table 1: Effect of ROVABIO® SPIKY on the apparent metabolisable energy (AME) and nitrogen-
corrected AME (AMEn) content of the diets
AME
(MJ/kg dry matter)
AMEn
(MJ/kg dry matter)
Control 12.05b 11.72b
ROVABIO® SPIKY 12.38a 12.04a
a,b: Within one column, mean values with different superscripts are signiﬁcantly different (p < 0.05).
Table 2: Effect of ROVABIO® SPIKY on the performance of laying hens in the ﬁrst long-term trial
Daily feed
intake
(g)
Laying rate
(%)
Egg
weight
(g)
Daily egg
mass
(g)
Feed to egg mass
ratio
Mortality
(%)
Control 123.5a 95.4b 60.4 57.6 2.14a 2.98
ROVABIO®
SPIKY
121.7b 96.6a 60.4 58.3 2.09b 2.68
a,b: Within one column, mean values with different superscripts are signiﬁcantly different (p < 0.05).
11 Technical dossier/Section IV/Annex IV.1.1 and Supplementary information May 2016/Annex 2.
12 Technical dossier/Section IV/Annex IV.1.2.
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Mortality was below 3% and was not affected by the treatment. No differences between treatments
were observed in the body weight of the hens and in egg weight and mass. Enzyme addition at the
recommended dose increased the laying rate and decreased the feed intake and the feed to egg mass
ratio. No differences were found between treatments regarding the egg quality parameters measured
(data not shown).
In the second trial, a total of three hundred and eighty-four 20-week-old Hy Line brown laying hens
were placed in enriched cages in groups of eight hens and allocated to two dietary treatments,
representing 24 replicates per treatment.13 A basal diet based on wheat, wheat bran and soya bean
meal was either not supplemented (control) or supplemented with ROVABIO® SPIKY AP to provide
1,100 U xylanase and 760 U glucanase per kg feed (conﬁrmed by analysis). Diets were offered
ad libitum as mash for 196 days. Health status and mortality of the animals was monitored throughout
the study. Body weight was measured at the beginning and at the end of the trial. Feed intake was
monitored every 4 weeks throughout the study. All eggs produced were collected and weighed every
second day and fed to egg mass ratio was calculated. On week 42 of life, eight eggs per cage were
analysed for egg shell, yolk and albumen weights, albumen Haugh units and yolk colour. An ANOVA
was performed on the data with the cage as the experimental unit. Differences were considered
signiﬁcant at p < 0.05. The results are given in Table 3.
Three hens died during the study, one from the control diet and two from the treated group. No
signiﬁcant differences between treatments were observed in the body weight of the hens, feed intake,
laying rate, egg weight or egg mass. Enzyme addition at the recommended level decreased
signiﬁcantly the feed to egg mass ratio. No differences were found between treatments regarding the
egg quality parameters measured.
3.3.1.3. Conclusions on efﬁcacy for the target species
In one study, supplementation of the diets with the additive increased the AME and AMEn of the
diets offered to laying hens. In two other studies, ROVABIO® SPIKY improved the performance of the
laying hens. Therefore, the FEEDAP Panel concludes that the additive has the potential to be
efﬁcacious in laying hens at the recommended dose. The Panel considers that the efﬁcacy established
in laying hens applies also to breeding hens and as the mode of action of xylanase and glucanase can
be reasonably assumed to be the same in all avian species, the conclusions on the efﬁcacy for laying
hens can be extrapolated to include all minor poultry species for laying.
3.4. Post-market monitoring
The FEEDAP Panel considers that there is no need for speciﬁc requirements for a post-market
monitoring plan other than those established in the Feed Hygiene Regulation14 and good
manufacturing practice.
4. Conclusions
The new use of the additive would not change the conclusions drawn previously regarding the
safety for consumer, user and environment. The Panel concluded that the additive is safe for the
consumer and the environment; the additive is not irritant to the skin or eyes but should be considered
a potential skin sensitiser and potentially harmful if inhaled.
The additive is safe and efﬁcacious for all poultry species at the recommended dose (1,100 U
xylanase and 760 U glucanase per kg feed).
Table 3: Effect of ROVABIO® SPIKY on the performance of laying hens in the second long-term trial
Daily feed intake
(g)
Laying rate
(%)
Egg weight
(g)
Egg mass
(g/hen per day)
Feed to egg mass
Control 119.8 92.1 62.3 57.3 2.09a
ROVABIO® SPIKY 118.2 92.8 62.3 57.8 2.05b
a,b: Within one column, mean values with different superscripts are signiﬁcantly different (p < 0.05).
13 Technical dossier/Section IV/Annex IV.1.3.B and Supplementary information May 2016/Annex 3.
14 Regulation (EC) No 183/2005 of the European Parliament and of the Council of 12 January 2005 laying down requirements for
feed hygiene. OJ L 35, 8.2.2005, p. 1.
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